Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,841,670
-$78,654 QoQ
Shares Held
11,189
-6.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,035
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $23,629,551 across 10 Drug Manufacturers - General names. JNJ ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,874 | $5,846,022 | |
| 2 | ABBV |
AbbVie Inc.
|
15,684 | $3,946,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,837 | $3,191,554 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,189 | $2,841,670 | |
| 5 | AMGN |
Amgen Inc
|
6,512 | $2,358,125 | |
| 6 | PFE |
Pfizer Inc
|
76,265 | $1,836,461 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,183 | $1,681,524 | |
| 8 | NVS |
Novartis AG
|
8,587 | $1,345,754 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,841,670 | 11,189 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,920,324 | 11,947 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,174,318 | 39,499 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $8,512,075 | 45,907 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,964,212 | 12,859 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,238,674 | 13,499 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,475,605 | 17,118 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,909,049 | 24,121 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $3,618,336 | 24,756 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,861,657 | 18,090 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,607,530 | 35,776 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $5,485,982 | 35,223 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $5,966,333 | 36,046 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $5,582,790 | 36,018 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $7,108,219 | 40,239 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $6,325,299 | 38,720 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $8,750,532 | 49,296 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $8,487,367 | 47,889 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $8,180,909 | 47,822 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $7,343,243 | 45,469 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $6,373,296 | 38,687 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $5,789,064 | 35,224 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $4,233,049 | 26,897 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,802,341 | 12,106 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,670,262 | 11,877 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,119,981 | 8,541 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||